BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tosh DK, Janowsky A, Eshleman AJ, Warnick E, Gao ZG, Chen Z, Gizewski E, Auchampach JA, Salvemini D, Jacobson KA. Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters. J Med Chem 2017;60:3109-23. [PMID: 28319392 DOI: 10.1021/acs.jmedchem.7b00141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Valdés FZ, Luna VZ, Arévalo BR, Brown NV, Gutiérrez MC. Adenosine: Synthetic Methods of Its Derivatives and Antitumor Activity. Mini Rev Med Chem 2018;18:1684-701. [PMID: 29769005 DOI: 10.2174/1389557518666180516163539] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Jacobson KA, Salmaso V, Suresh RR, Tosh DK. Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets. RSC Med Chem 2021;12:1808-25. [PMID: 34825182 DOI: 10.1039/d1md00167a] [Reference Citation Analysis]
3 Podlewska S, Bugno R, Lacivita E, Leopoldo M, Bojarski AJ, Handzlik J. Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2. Int J Mol Sci 2021;22:1035. [PMID: 33494248 DOI: 10.3390/ijms22031035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Navratna V, Tosh DK, Jacobson KA, Gouaux E. Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation. PLoS One 2018;13:e0200085. [PMID: 29965988 DOI: 10.1371/journal.pone.0200085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Wang M, Wang N, Liu X, Qiao C, He L. Tungstate catalysis: pressure-switched 2- and 6-electron reductive functionalization of CO 2 with amines and phenylsilane. Green Chem 2018;20:1564-70. [DOI: 10.1039/c7gc03416d] [Cited by in Crossref: 46] [Cited by in F6Publishing: 1] [Article Influence: 11.5] [Reference Citation Analysis]
6 Navratna V, Gouaux E. Insights into the mechanism and pharmacology of neurotransmitter sodium symporters. Curr Opin Struct Biol 2019;54:161-70. [PMID: 30921707 DOI: 10.1016/j.sbi.2019.03.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
7 Jacobson KA, Tosh DK, Toti KS, Ciancetta A. Polypharmacology of conformationally locked methanocarba nucleosides. Drug Discov Today 2017;22:1782-91. [PMID: 28781163 DOI: 10.1016/j.drudis.2017.07.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Xue W, Fu T, Zheng G, Tu G, Zhang Y, Yang F, Tao L, Yao L, Zhu F. Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters. CMC 2020;27:3830-76. [DOI: 10.2174/0929867325666181009123218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
9 Tosh DK, Salmaso V, Rao H, Campbell R, Bitant A, Gao ZG, Auchampach JA, Jacobson KA. Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists. ACS Med Chem Lett 2020;11:1935-41. [PMID: 33062176 DOI: 10.1021/acsmedchemlett.9b00637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tosh DK, Ciancetta A, Mannes P, Warnick E, Janowsky A, Eshleman AJ, Gizewski E, Brust TF, Bohn LM, Auchampach JA, Gao ZG, Jacobson KA. Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega 2018;3:12658-78. [PMID: 30411015 DOI: 10.1021/acsomega.8b01237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
11 Jacobson KA, Tosh DK, Gao Z, Yu J, Suresh RR, Rao H, Romagnoli R, Baraldi PG, Aghazadeh Tabrizi M. Medicinal Chemistry of the A3 Adenosine Receptor. In: Borea PA, Varani K, Gessi S, Merighi S, Vincenzi F, editors. The Adenosine Receptors. Cham: Springer International Publishing; 2018. pp. 169-98. [DOI: 10.1007/978-3-319-90808-3_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Abel B, Tosh DK, Durell SR, Murakami M, Vahedi S, Jacobson KA, Ambudkar SV. Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). Mol Pharmacol 2019;96:180-92. [PMID: 31127007 DOI: 10.1124/mol.118.115295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Xia L, Kyrizaki A, Tosh DK, van Duijl TT, Roorda JC, Jacobson KA, IJzerman AP, Heitman LH. A binding kinetics study of human adenosine A3 receptor agonists. Biochem Pharmacol 2018;153:248-59. [PMID: 29305857 DOI: 10.1016/j.bcp.2017.12.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]